Patent classifications
A61F2002/3647
IMPLANT COMPONENT
A humeral implant component connectable to another humeral implant component, the humeral implant component comprising: a longitudinal axis, a first end and a second end, the first end and the second end opposing each other along the longitudinal axis of the humeral implant component, and an interface part for connecting the humeral implant component to the other humeral implant component, wherein the interface part is tapered along the longitudinal axis in a direction from the second end to the first end, the interface part being engageable with a tapered interface part of the other humeral implant component to form a tapered connection between the humeral implant component and the other humeral implant component, wherein the humeral implant component further comprises a through hole extending along the longitudinal axis for locking the tapered connection by a longitudinal fastener.
Total joint replacement infection control devices and methods
An orthopedic system for delivery of a therapeutic agent to a bone includes an elongate stem adapted to be inserted into an intramedullary canal, an inlet configured to receive the therapeutic agent, and one or more outlets configured to deliver the therapeutic agent to the bone. The elongate stem may comprise one or more protrusions to engage the bone, and one or more channels extending longitudinally therein, fluidly coupled to the inlet. The therapeutic agent flows from the inlet through the one or more channels and exits into the intramedullary canal through the one or more outlets. The system may be configured to allow one or more dimensions of the system to be adjusted to accommodate the anatomy of a patient.
TOTAL JOINT REPLACEMENT INFECTION CONTROL DEVICES AND METHODS
An orthopedic system for delivery of a therapeutic agent to a bone includes an elongate stem adapted to be inserted into an intramedullary canal, an inlet configured to receive the therapeutic agent, and one or more outlets configured to deliver the therapeutic agent to the bone. The elongate stem may comprise one or more protrusions to engage the bone, and one or more channels extending longitudinally therein, fluidly coupled to the inlet. The therapeutic agent flows from the inlet through the one or more channels and exits into the intramedullary canal through the one or more outlets. The system may be configured to allow one or more dimensions of the system to be adjusted to accommodate the anatomy of a patient.
IMPLANT COMPONENT ASSEMBLY
The present disclosure provides an implant component assembly for a joint replacement. The assembly comprises an implant component, the implant component including an interface part for attaching another implant component and an assembly channel. The assembly further comprises an assembly screw for securing the other implant component to the implant component, the assembly screw having a longitudinal axis, a screw head, and a screw shank and being insertable into the assembly channel. A screw retention unit of the assembly is configured for keeping the assembly screw within the assembly channel and allowing rotation of the assembly screw about the longitudinal axis.
Femoral stem and post system for hip prosthesis
A femoral stem for use in hip replacement surgery, specifically hip replacement surgery in dogs and similar animals but also inclusive to implants used in humans. More particularly, the invention is directed to a femoral stem that includes a lateral bolt or post that protrudes through the cortex or wall of bone opposite the neck of the femoral stem. The lateral bolt or post reduces the occurrence of subsidence in implanted femoral stems. The lateral bolt or post provides an anchor point on the cortex or wall of bone as opposed to relying solely on the compression of the femoral stem against the wall of the bony canal of the femur being implanted.
HIP IMPLANT SYSTEM
Hip implant systems described herein can include a distal stem, a proximal body, and a fastener. In some embodiments, the distal stem can include a cavity configured to receive the fastener when a portion of the distal stem is positioned within the proximal body. In some embodiments, the distal stem can include a threaded exterior surface configured to mate with a fastener when a portion of the distal stem is positioned within the proximal body. In some embodiments, a distal end of the distal stem can include an anterior relief configured to conform to interior surface of a femoral canal of a patient.
Trial neck apparatus and method
A trial neck (30) and a method for trialling a neck of an orthopedic implant in a hip replacement procedure. The method includes inserting a broach (10) into a medullary canal of a femur and connecting a distal end of a trial neck to a proximal end (12) of the broach. The trial neck includes a proximal end connectable to a trial head. The trial neck includes a body portion extending along a neck axis (5) of the trial neck between the distal end and the proximal end. The proximal end includes a male connector for connection to a corresponding female connector of a trial head. The male connector includes a plurality of connection members (34A, 34B) extending parallel to the neck axis. The connection members are separated by one or more elongate slots (50) including at least one kink (52) forming an interlock between the connection members separated by that slot. The connection members are resiliently deflectable.
Hip or shoulder prosthesis and placement instruments
A hip/shoulder prosthesis includes: a head component; a metaphyseal component; a diaphyseal nail, and a locking device. The head component includes: a front face and rear face; with a bore, and first and second shaped recesses in the rear face. The metaphyseal component includes: a central transverse aperture at an angle to the metaphyseal component's axis; a first end configured for threaded engagement within the bore of the head component; and a longitudinal hole that begins at the second end, transects the transverse aperture and reaches the first end, to receive the locking device. The diaphyseal nail is inserted in the femoral or humeral canal, and includes: fastening apertures that receive corresponding screws for fastening the diaphyseal nail to the femur or humerus; a portion configured to he received within, and engage, the transverse aperture of the metaphyseal component, and a transverse hole configured to receive the locking device.
Hip or shoulder prosthesis and placement instruments
A hip/shoulder prosthesis includes: a head component; a metaphyseal component; a diaphyseal nail, and a locking device. The head component includes: a front face and rear face; with a bore, and first and second shaped recesses in the rear face. The metaphyseal component includes: a central transverse aperture at an angle to the metaphyseal component's axis; a first end configured for threaded engagement within the bore of the head component; and a longitudinal hole that begins at the second end, transects the transverse aperture and reaches the first end, to receive the locking device. The diaphyseal nail is inserted in the femoral or humeral canal, and includes: fastening apertures that receive corresponding screws for fastening the diaphyseal nail to the femur or humerus; a portion configured to be received within, and engage, the transverse aperture of the metaphyseal component, and a transverse hole configured to receive the locking device.
JOINT IMPLANT FOR ADMINISTERING A PHARMACEUTICAL PRODUCT
A joint implant component (1, 1′; 101; 201) for administering a pharmaceutical product is disclosed, which comprises an implant shaft (10, 10′; 110; 210), a joint section (20, 20′; 120; 220) arranged at the proximal end of the implant shaft, a flush supply opening (3, 3′; 103; 203) and a backflush opening (4, 4′; 104; 204). At least one shaft flush channel (11, 11′; 111; 211) and one shaft backflush channel (12, 12′; 112; 212) extend along the implant shaft inside the implant shaft. The shaft flush channel is connected to the outside of the implant shaft via shaft flush holes (13, 13′; 112; 113) for discharging the pharmaceutical product, and the shaft backflush channel is connected to the outside of the implant shaft via at least one shaft backflush hole (14, 14′; 114; 214) for receiving the discharged pharmaceutical product. The flush supply opening is fluidically connected to the proximal end of the shaft flush channel and the backflush opening is fluidically connected to the proximal end of the shaft backflush channel. Also disclosed is a joint implant comprising two such joint implant components which are connected to one another by means of joint surface parts (30, 40; 230) and are pivotable relative to one another.